ADC Therapeutics SA
NYSE:ADCT
ADC Therapeutics SA
NYSE:ADCT
Price:
4.96 USD
11.71%
Updated:
Apr 18, 2024
ADC Therapeutics SA
Change in Working Capital
Last
Value
3-Years CAGR
5-Years CAGR
|
ADC Therapeutics SA
Change in Working Capital Peer Comparison
Comparables:
ACIU
CRSP
BSLN
IDIA
KURN
Competitive Change in Working Capital Analysis
Latest Figures & CAGR of Competitors
Latest Figures & CAGR of Competitors
| Company | Change in Working Capital | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
|---|---|---|---|---|---|
|
|
ADC Therapeutics SA
NYSE:ADCT
|
Change in Working Capital
$-65.9m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
AC Immune SA
NASDAQ:ACIU
|
Change in Working Capital
CHf-14.7m
|
CAGR 3-Years
-45%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
CRISPR Therapeutics AG
NASDAQ:CRSP
|
Change in Working Capital
$-193.6m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Basilea Pharmaceutica AG
SIX:BSLN
|
Change in Working Capital
CHf-4m
|
CAGR 3-Years
49%
|
CAGR 5-Years
41%
|
CAGR 10-Years
24%
|
|
|
Idorsia Ltd
SIX:IDIA
|
Change in Working Capital
CHf-64.7m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Kuros Biosciences AG
SIX:KURN
|
Change in Working Capital
CHf-3.8m
|
CAGR 3-Years
-70%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
See Also
What is ADC Therapeutics SA's Change in Working Capital?
Change in Working Capital
-65.9m
USD
-65.9m
USD
Based on the financial report for Dec 31, 2023, ADC Therapeutics SA's Change in Working Capital amounts to -65.9m USD.
What is ADC Therapeutics SA's Change in Working Capital growth rate?
Change in Working Capital CAGR 1Y
0%
0%
Over the last year, the Change in Working Capital growth was 0%.
You don't have any saved screeners yet
